Melatonin protects against experimental immune ovarian failure in mice

Tatyana Voznesenskaya1, Nataliya Makogon, Tatyana Bryzgina

  • 1Department of Immunology, Bogomoletz Institute of Physiology, Ukrainian Academy of Sciences, 4 Bogomoletz str., 01024 Kyiv, Ukraine. voz@biph.kiev.ua

Reproductive Biology
|December 7, 2007
PubMed

Experimental immune ovarian failure induced in CBA mice by either administration of xenogenic anti-ovarian antibodies or immunization with allogenic ovarian extracts impaired the meiotic maturation of oocytes and increased apoptosis of follicular cells. Immunization was accompanied with the inflammation and active immune reaction, as shown by the enlargement of regional lymph nodes, the increase of apoptosis in cultured lymph node cells and the increase of band and segmented neutrophil percentage in the blood. Triple injections of melatonin (5 mg/kg of the body weight) an hour before antibodies administration restored the meiotic maturation of oocytes and supported the survival of follicular and lymph node cells. In contrast, melatonin application upon immunization was not effective to prevent the ovary impairment and cell death. It is concluded that melatonin protects against immune ovary failure induced by xenogenic anti-ovarian antibodies.

Related Concept Videos